These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34931282)

  • 1. Caspofungin Population Pharmacokinetic Analysis in Plasma and Peritoneal Fluid in Septic Patients with Intra-Abdominal Infections: A Prospective Cohort Study.
    Garbez N; Mbatchi LC; Wallis SC; Muller L; Lipman J; Roberts JA; Lefrant JY; Roger C
    Clin Pharmacokinet; 2022 May; 61(5):673-686. PubMed ID: 34931282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Cohort Study of Micafungin Population Pharmacokinetic Analysis in Plasma and Peritoneal Fluid in Septic Patients with Intra-abdominal Infections.
    Garbez N; Mbatchi L; Wallis SC; Muller L; Lipman J; Roberts JA; Lefrant JY; Roger C
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0230720. PubMed ID: 33846133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics/Pharmacodynamics of Caspofungin in Plasma and Peritoneal Fluid of Liver Transplant Recipients.
    Pressiat C; Ait-Ammar N; Daniel M; Hulin A; Botterel F; Levesque E
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0118721. PubMed ID: 34662185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis.
    Grau S; Luque S; Campillo N; Samsó E; Rodríguez U; García-Bernedo CA; Salas E; Sharma R; Hope WW; Roberts JA
    J Antimicrob Chemother; 2015 Oct; 70(10):2854-61. PubMed ID: 26180134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection.
    García-de-Lorenzo A; Luque S; Grau S; Agrifoglio A; Cachafeiro L; Herrero E; Asensio MJ; Sánchez SM; Roberts JA
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5914-21. PubMed ID: 27458229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill Patients.
    Märtson AG; van der Elst KCM; Veringa A; Zijlstra JG; Beishuizen A; van der Werf TS; Kosterink JGW; Neely M; Alffenaar JW
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32660990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration.
    Pérez-Pitarch A; Ferriols-Lisart R; Aguilar G; Ezquer-Garín C; Belda FJ; Guglieri-López B
    Int J Antimicrob Agents; 2018 Jan; 51(1):115-121. PubMed ID: 28666752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose Reduction of Caspofungin in Intensive Care Unit Patients with Child Pugh B Will Result in Suboptimal Exposure.
    Martial LC; Brüggemann RJ; Schouten JA; van Leeuwen HJ; van Zanten AR; de Lange DW; Muilwijk EW; Verweij PE; Burger DM; Aarnoutse RE; Pickkers P; Dorlo TP
    Clin Pharmacokinet; 2016 Jun; 55(6):723-33. PubMed ID: 26649870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Loading Dose of Caspofungin in Pharmacokinetic-Pharmacodynamic Target Attainment for Severe Candidiasis Infections in Patients in Intensive Care Units: the CASPOLOAD Study.
    Bailly S; Gautier-Veyret E; Lê MP; Bouadma L; Andremont O; Neuville M; Mourvillier B; Sonneville R; Magalhaes E; Lebut J; Radjou A; Smonig R; Wolff M; Massias L; Dupuis C; Timsit JF
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32958709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and Pharmacodynamics of Levornidazole in Patients With Intra-abdominal AnaerobicInfection.
    Wu H; Xie S; Yu J; Chen Y; Wu J; Guo B; Zhu Z; Zhou Y; Wang Z; Zhang J
    Clin Ther; 2018 Sep; 40(9):1548-1555. PubMed ID: 30146271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of piperacillin-tazobactam in plasma, peritoneal fluid and peritoneum of surgery patients, and dosing considerations based on site-specific pharmacodynamic target attainment.
    Murao N; Ohge H; Ikawa K; Watadani Y; Uegami S; Shigemoto N; Shimada N; Yano R; Kajihara T; Uemura K; Murakami Y; Morikawa N; Sueda T
    Int J Antimicrob Agents; 2017 Sep; 50(3):393-398. PubMed ID: 28694230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of echinocandin regimens by pharmacokinetic/pharmacodynamic analysis against Candida spp. in paediatric patients.
    Xu G; Zhu L; Liao S; Ge T; Yang J
    Int J Antimicrob Agents; 2015 Dec; 46(6):631-41. PubMed ID: 26602452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance.
    Gioia F; Gomez-Lopez A; Alvarez ME; Gomez-García de la Pedrosa E; Martín-Davila P; Cuenca-Estrella M; Moreno S; Fortun J
    Int J Infect Dis; 2020 Dec; 101():24-28. PubMed ID: 32937195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of Voriconazole in Peritoneal Fluid of Critically Ill Patients.
    Lin XB; Hu XG; Tang ZX; Guo PH; Liu XM; Liang T; Xia YZ; Lui KY; Chen P; Tang KJ; Chen X; Cai CJ
    Antimicrob Agents Chemother; 2023 May; 67(5):e0172122. PubMed ID: 37022169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration.
    Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Brüggemann RJ; Lefrant JY; Roberts JA
    Clin Pharmacokinet; 2017 Sep; 56(9):1057-1068. PubMed ID: 28035589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation.
    Niu CH; Xu H; Gao LL; Nie YM; Xing LP; Yu LP; Wu SL; Wang Y
    Front Pharmacol; 2020; 11():184. PubMed ID: 32194415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic model-guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction.
    Lin XB; Lui KY; Guo PH; Liu XM; Liang T; Hu XG; Tong L; Wu JJ; Xia YZ; Chen P; Zhong GP; Chen X; Cai CJ
    Pharmacotherapy; 2022 Jan; 42(1):23-33. PubMed ID: 34655497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis.
    Pařízková RČ; Martínková J; Havel E; Šafránek P; Kaška M; Astapenko D; Bezouška J; Chládek J; Černý V
    Crit Care; 2021 Jul; 25(1):251. PubMed ID: 34274013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy.
    Carrié C; Delzor F; Roure S; Dubuisson V; Petit L; Molimard M; Breilh D; Biais M
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of flomoxef in plasma, peritoneal fluid, peritoneum, and subcutaneous adipose tissue of patients undergoing lower gastrointestinal surgery: Dosing considerations based on site-specific pharmacodynamic target attainment.
    Hirano T; Ohge H; Ikawa K; Uegami S; Watadani Y; Shigemoto N; Yoshimura K; Kitagawa H; Kaiki Y; Morikawa N; Takahashi S
    J Infect Chemother; 2023 Feb; 29(2):186-192. PubMed ID: 36341996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.